A Ranbaxy spokesman declined comment but people familiar with Ranbaxy marketing plans said the company's share would cross 50% in about a m...

Ranbaxy may hand over its L American mkting operations to Daiichi Sankyo, a move could be a precursor to the Indian drugmaker's exit from s...

The decree is unprecedented in its scope, and requires the drug maker to take a range of actions to correct its violations and ensure they ...

Ranbaxy Laboratories has started discussions to make low-cost version of Lipitor, which the drugmaker hopes to roll out in the US by Novemb...

Ranbaxy Laboratories, India’s largest drug maker, on Friday reported a 25% fall in second-quarter net profit, sending the company’s shares ...

AstraZeneca is awaiting approval from USFDA but we expect to start shipping the product in the second half of this year.

The drugmaker's net profit during the quarter ended March 31 was just one third of its profit of 960 crore during the same quarter last yea...

Ranbaxy by revenues has recorded the slowest domestic sales growth rate among its peers in the first seven months of this year, despite boo...

Seven months after Ranbaxy kicked off its aggressive plan to regain its position as the largest drug seller in India by hiring 1,500 sales ...

Ahmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...

Ranbaxy Laboratories is voluntarily recalling two consignments of one of its antibiotics from the US market.

Drug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...

Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...

Ranbaxy's French unit has been raided by European antitrust officials as part of a probe on cozy drug settlements which allegedly delay the...

Supplies to Astrazeneca which could have potentially brought revenues of $40 million this year (May-December 2009) has been delayed by 2-3 ...

Ranbaxy Laboratories, India's largest company by sales, is expected to start supplying raw materials for anti-ulcer drug esomeprazole magne...

After the two leading pharma multinationals recently increased their stakes in their Indian units, people connected with the industry say t...